Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer.
- Published in:
- Prostate, 2002, v. 50, n. 1, p. 54, doi. 10.1002/pros.10032
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2002 AND VI 50 AND IP 1
Results: 8
1
2
Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and <sup>90</sup>yttrium-DOTA-peptide-ChL6.
- Published in:
- Prostate, 2002, v. 50, n. 1, p. 27, doi. 10.1002/pros.10029
- By:
- Publication type:
- Article
3
Evidence for stem cells in cultures of mouse prostate epithelial cells.
- Published in:
- Prostate, 2002, v. 50, n. 1, p. 46, doi. 10.1002/pros.10031
- By:
- Publication type:
- Article
4
Vitamin D<sub>3</sub> analogue inhibits keratinocyte growth factor signaling and induces apoptosis in human prostate cancer cells.
- Published in:
- Prostate, 2002, v. 50, n. 1, p. 15, doi. 10.1002/pros.10028
- By:
- Publication type:
- Article
5
Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines.
- Published in:
- Prostate, 2002, v. 50, n. 1, p. 38, doi. 10.1002/pros.10030
- By:
- Publication type:
- Article
6
Phospholipase A<sub>2</sub> degradation products modulate epithelial and stromal 5α-reductase activity of human benign prostatic hyperplasia in vitro.
- Published in:
- Prostate, 2002, v. 50, n. 1, p. 4, doi. 10.1002/pros.10027
- By:
- Publication type:
- Article
7
Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP.
- Published in:
- Prostate, 2002, v. 50, n. 1, p. 64, doi. 10.1002/pros.10033
- By:
- Publication type:
- Article
8
Increased serum insulin associated with increased risk of prostate cancer recurrence.
- Published in:
- Prostate, 2002, v. 50, n. 1, p. 1, doi. 10.1002/pros.10026
- By:
- Publication type:
- Article